PL2148670T3 - Dostosowywanie dawki tapentadolu - Google Patents
Dostosowywanie dawki tapentadoluInfo
- Publication number
- PL2148670T3 PL2148670T3 PL08749016T PL08749016T PL2148670T3 PL 2148670 T3 PL2148670 T3 PL 2148670T3 PL 08749016 T PL08749016 T PL 08749016T PL 08749016 T PL08749016 T PL 08749016T PL 2148670 T3 PL2148670 T3 PL 2148670T3
- Authority
- PL
- Poland
- Prior art keywords
- tapentadol
- titration
- administration
- unitbcontaining
- unitacontaining
- Prior art date
Links
- KWTWDQCKEHXFFR-SMDDNHRTSA-N tapentadol Chemical compound CN(C)C[C@H](C)[C@@H](CC)C1=CC=CC(O)=C1 KWTWDQCKEHXFFR-SMDDNHRTSA-N 0.000 title abstract 4
- 229960005126 tapentadol Drugs 0.000 title abstract 4
- 238000004448 titration Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Adhesive Tapes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07008218A EP1985292A1 (en) | 2007-04-23 | 2007-04-23 | Titration of tapentadol |
| PCT/EP2008/003178 WO2008128740A1 (en) | 2007-04-23 | 2008-04-21 | Titration of tapentadol |
| EP08749016A EP2148670B1 (en) | 2007-04-23 | 2008-04-21 | Titration of tapentadol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2148670T3 true PL2148670T3 (pl) | 2012-04-30 |
Family
ID=38123877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08749016T PL2148670T3 (pl) | 2007-04-23 | 2008-04-21 | Dostosowywanie dawki tapentadolu |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US20090012180A1 (enExample) |
| EP (5) | EP1985292A1 (enExample) |
| JP (4) | JP5933176B2 (enExample) |
| KR (3) | KR20150027840A (enExample) |
| CN (1) | CN101730530B (enExample) |
| AT (1) | ATE534378T1 (enExample) |
| AU (1) | AU2008241013B2 (enExample) |
| CA (1) | CA2683786C (enExample) |
| CY (1) | CY1112320T1 (enExample) |
| DK (1) | DK2148670T3 (enExample) |
| ES (1) | ES2378255T3 (enExample) |
| HR (1) | HRP20120147T1 (enExample) |
| IL (1) | IL201479A (enExample) |
| MX (1) | MX2009011444A (enExample) |
| NZ (1) | NZ580415A (enExample) |
| PL (1) | PL2148670T3 (enExample) |
| PT (1) | PT2148670E (enExample) |
| RU (1) | RU2472497C2 (enExample) |
| SI (1) | SI2148670T1 (enExample) |
| WO (1) | WO2008128740A1 (enExample) |
| ZA (1) | ZA200907355B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1985292A1 (en) | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
| AU2009340504A1 (en) * | 2008-10-30 | 2010-08-26 | Grunenthal Gmbh | Novel and potent tapentadol dosage forms |
| US8870876B2 (en) * | 2009-02-13 | 2014-10-28 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| US8277459B2 (en) * | 2009-09-25 | 2012-10-02 | Tarsus Medical Inc. | Methods and devices for treating a structural bone and joint deformity |
| US8652141B2 (en) | 2010-01-21 | 2014-02-18 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| US20130116333A1 (en) * | 2010-05-05 | 2013-05-09 | Ratiopharm Gmbh | Solid tapentadol in non-crystalline form |
| US8696719B2 (en) | 2010-06-03 | 2014-04-15 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
| AU2011273907B2 (en) * | 2010-06-30 | 2015-03-19 | Grunenthal Gmbh | Tapentadol for use in the treatment of Irritable Bowel Syndrome |
| DK3656765T3 (da) * | 2010-07-23 | 2021-06-14 | Gruenenthal Gmbh | Salte eller co-krystaller af 3-(3-dimethylamin-1-ethyl-2-methyl-propyl)-phenol |
| CN101948397A (zh) * | 2010-09-07 | 2011-01-19 | 天津泰普药品科技发展有限公司 | 镇痛药他喷他多重要中间体的制备方法 |
| BR112013022556A8 (pt) | 2011-03-04 | 2018-01-16 | Gruenenthal Gmbh | composição farmacêutica aquosa semissólida contendo tapentadol, seu uso e uso de tapentadol |
| EP2680833B1 (en) * | 2011-03-04 | 2016-03-02 | Grünenthal GmbH | Parenteral administration of tapentadol |
| LT3287123T (lt) | 2011-03-04 | 2020-06-10 | Grünenthal GmbH | Vandeninė farmacinė tapentadolio kompozicija, skirta gerti |
| PT2694049T (pt) | 2011-04-05 | 2019-02-06 | Gruenenthal Gmbh | Tapentadol para prevenir a cronicidade da dor |
| WO2012136351A1 (en) * | 2011-04-05 | 2012-10-11 | Grünenthal GmbH | Tapentadol for treating pain associated with trigeminal neuralgia |
| ES2646363T3 (es) | 2011-04-29 | 2017-12-13 | Grünenthal GmbH | Tapentadol para la prevención y el tratamiento de la depresión y la ansiedad |
| PL2968182T3 (pl) * | 2013-03-15 | 2018-10-31 | SpecGx, LLC | Zniechęcająca do nadużywania stała postać dawkowania dla natychmiastowego uwalniania z funkcjonalnym rowkiem |
| EP2845625A1 (en) * | 2013-09-04 | 2015-03-11 | Grünenthal GmbH | Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome |
| EA036258B1 (ru) | 2015-03-27 | 2020-10-20 | Грюненталь Гмбх | Стабильный препарат для парентерального введения тапентадола |
| PT3302454T (pt) * | 2015-05-26 | 2021-04-01 | Technophage Investig E Desenvolvimento Em Biotecnologia Sa | Composições para utilização no tratamento da doença de parkinson e distúrbios associados |
| CN109069483A (zh) | 2016-02-29 | 2018-12-21 | 格吕伦塔尔有限公司 | 西博帕多的滴定 |
| WO2018055070A1 (en) | 2016-09-23 | 2018-03-29 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
| ES3010208T3 (en) | 2020-03-16 | 2025-04-01 | Gruenenthal Gmbh | Scored tablet comprising tapentadol |
| CN117042738A (zh) * | 2021-03-17 | 2023-11-10 | 埃科特莱茵药品有限公司 | 药物剂量系统 |
| WO2022234076A1 (en) * | 2021-05-07 | 2022-11-10 | Grünenthal GmbH | Tapentadol for treating neuropathic pain in covid-19 patients |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| JPS6327805A (ja) | 1986-07-21 | 1988-02-05 | Sumitomo Electric Ind Ltd | 光フアイバの接続用部材及びそれを用いた接続方法 |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| US6339105B1 (en) * | 1999-10-12 | 2002-01-15 | Ortho-Mcneil Pharmaceutical, Inc. | Analgesic regimen |
| PE20030527A1 (es) * | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
| EP1572167B1 (en) | 2002-12-13 | 2008-07-09 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| US7413749B2 (en) | 2003-03-11 | 2008-08-19 | Purdue Pharma L.P. | Titration dosing regimen for controlled release tramadol |
| DE102007019417A1 (de) * | 2007-04-23 | 2008-11-13 | Grünenthal GmbH | Tapentadol zur Schmerzbehandlung bei Arthrose |
| EP1985292A1 (en) * | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
-
2007
- 2007-04-23 EP EP07008218A patent/EP1985292A1/en not_active Withdrawn
-
2008
- 2008-04-21 US US12/106,695 patent/US20090012180A1/en not_active Abandoned
- 2008-04-21 MX MX2009011444A patent/MX2009011444A/es active IP Right Grant
- 2008-04-21 CN CN200880021172XA patent/CN101730530B/zh not_active Expired - Fee Related
- 2008-04-21 ES ES08749016T patent/ES2378255T3/es active Active
- 2008-04-21 JP JP2010504517A patent/JP5933176B2/ja active Active
- 2008-04-21 EP EP19189638.0A patent/EP3603630A1/en not_active Withdrawn
- 2008-04-21 EP EP16192734.8A patent/EP3143993A1/en not_active Withdrawn
- 2008-04-21 SI SI200830540T patent/SI2148670T1/sl unknown
- 2008-04-21 EP EP11008908A patent/EP2422778A1/en not_active Withdrawn
- 2008-04-21 HR HR20120147T patent/HRP20120147T1/hr unknown
- 2008-04-21 EP EP08749016A patent/EP2148670B1/en not_active Revoked
- 2008-04-21 NZ NZ580415A patent/NZ580415A/en not_active IP Right Cessation
- 2008-04-21 RU RU2009142940/15A patent/RU2472497C2/ru active
- 2008-04-21 PT PT08749016T patent/PT2148670E/pt unknown
- 2008-04-21 PL PL08749016T patent/PL2148670T3/pl unknown
- 2008-04-21 CA CA2683786A patent/CA2683786C/en active Active
- 2008-04-21 KR KR20157003922A patent/KR20150027840A/ko not_active Ceased
- 2008-04-21 AU AU2008241013A patent/AU2008241013B2/en active Active
- 2008-04-21 KR KR1020097024357A patent/KR20100017267A/ko not_active Ceased
- 2008-04-21 AT AT08749016T patent/ATE534378T1/de active
- 2008-04-21 KR KR1020177037810A patent/KR102078999B1/ko active Active
- 2008-04-21 DK DK08749016.5T patent/DK2148670T3/da active
- 2008-04-21 WO PCT/EP2008/003178 patent/WO2008128740A1/en not_active Ceased
-
2009
- 2009-10-13 IL IL201479A patent/IL201479A/en active IP Right Grant
- 2009-10-20 ZA ZA200907355A patent/ZA200907355B/xx unknown
-
2012
- 2012-02-06 CY CY20121100123T patent/CY1112320T1/el unknown
-
2015
- 2015-11-18 US US14/945,289 patent/US20160074342A1/en not_active Abandoned
-
2016
- 2016-01-21 JP JP2016009738A patent/JP2016128468A/ja active Pending
- 2016-12-05 US US15/369,257 patent/US20170079938A1/en not_active Abandoned
-
2017
- 2017-09-28 JP JP2017187306A patent/JP2018030864A/ja active Pending
-
2019
- 2019-04-10 JP JP2019074538A patent/JP2019131598A/ja active Pending
- 2019-06-12 US US16/439,135 patent/US11344512B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL201479A0 (en) | Titration of tapentadol | |
| MX2010009222A (es) | Soluciones farmaceuticas, proceso de preparacion y usos terapeuticos. | |
| MY151048A (en) | Use of flibanserin for the treatment of post-menopausal sexual desire disorders | |
| MX2009002196A (es) | Oblea de buprenorfina para terapia de sustitucion de farmacos. | |
| MY153408A (en) | Novel methods | |
| WO2010014690A3 (en) | Medical devices for therapeutic agent delivery | |
| UA105210C2 (ru) | Противораковая вакцина и ее применение | |
| MX2011007930A (es) | Conjugados de insulina cristalina. | |
| MX356210B (es) | Formulaciones de polimero acrilico. | |
| IN2012DN01435A (enExample) | ||
| WO2008087186A3 (en) | Peptides for use in the treatment of obesity | |
| CY1115455T1 (el) | Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας | |
| TN2012000515A1 (en) | Pharmaceutical compositions of co-crystals of tramadol and coxibs | |
| WO2011026125A3 (en) | Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen | |
| IN2012DN01434A (enExample) | ||
| MX2010001449A (es) | Bromhidrato de bupropion y aplicaciones terapeuticas. | |
| WO2008087188A3 (en) | Peptides for use in the treatment of obesity | |
| WO2012100043A3 (en) | Controlled release oral pharmaceutical dosage forms comprising mgbg | |
| MY150931A (en) | Substituted oxazolidinones and their use | |
| MX2009011999A (es) | Extruidos con enmascaramiento del sabor mejorado. | |
| MX2009008108A (es) | Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno. | |
| WO2009074498A8 (en) | Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate | |
| MX2009008813A (es) | Composicion farmaceutica que contiene floroglucinol y paracetamol. | |
| WO2007135123A3 (en) | Mirtazapine for the treatment of neuropathic pain | |
| EA201000738A1 (ru) | Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата |